申请人:Treeel Co.,Ltd 주식회사 트리엘(120160970130) Corp. No ▼ 134511-0269660BRN ▼582-87-00143
公开号:KR20180084716A
公开(公告)日:2018-07-25
본 발명은 하기 [화학식 A] 내지 [화학식 C] 중 어느 하나로 표시되는 비닐페닐옥시기를 포함하는 화합물 및 이를 포함하는 감광성 포토레지스트 조성물에 관한 것으로서, 상기 [화학식 A] 내지 [화학식 C]는 발명의 상세한 설명에 기재된 바와 같다.
This invention relates to a compound containing a vinylphenyloxy group represented by either [chemical formula A] to [chemical formula C], and a photosensitive photoresist composition containing the compound, wherein [chemical formula A] to [chemical formula C] are as described in the detailed description of the invention.
[EN] SSAO INHIBITORS AND USE THEREOF<br/>[FR] INHIBITEURS DE SSAO ET LEUR UTILISATION
申请人:ECCOGENE SHANGHAI CO LTD
公开号:WO2021083209A1
公开(公告)日:2021-05-06
Provided are a compound of formula (I') or (I), a pharmaceutically acceptable salt, hydrate, solvate, prodrug, stereoisomer, or tautomer thereof, which modulates the activity of SSAO, a pharmaceutical composition comprising a compound of formula (I') or (I), and a method of treating or preventing a disease in which SSAO plays a role.
[EN] HPK1 INHIBITORS, PREPARATION METHOD AND APPLICATION THEREOF<br/>[FR] INHIBITEURS D'HPK1, PROCÉDÉ DE PRÉPARATION ET UTILISATION ASSOCIÉS
申请人:ZHUHAI YUFAN BIOTECHNOLOGIES CO LTD
公开号:WO2019206049A1
公开(公告)日:2019-10-31
Disclosed are HPK-1 inhibitors having a structure represented by Formula (X), pharmaceutical compositions comprising the HPK-1 inhibitors, methods of using the HPK-1 inhibitors, such as treating cancers, methods of preparing the HPK-1 inhibitors, and the synthetic intermediates.
Darstellung und komplexbildung von polyazacycloalkan-N-essigsäuren
作者:H. Stetter、W. Frank、R. Mertens
DOI:10.1016/s0040-4020(01)97695-1
日期:1981.1
A series of polyazacycloalkane-N-acetic acids, varying in ring size from 12–18 members and in alkylgroups substitution were synthesized and their complexing properties were investigated in dependence upon conformations of the donor atoms.
Synthesis and evaluation of novel potent TSPO PET ligands with 2-phenylpyrazolo[1,5-a]pyrimidin-3-yl acetamide
作者:Van Hieu Tran、Hyunjun Park、Jaekyung Park、Young-Do Kwon、Shinwoo Kang、Jae Ho Jung、Keun-A Chang、Byung Chul Lee、Sang-Yoon Lee、Soosung Kang、Hee-Kwon Kim
DOI:10.1016/j.bmc.2019.07.036
日期:2019.9
a series of TSPO ligands (11a–c and 13a–d) with a 2-phenylpyrazolo[1,5-a]pyrimidin-3-yl acetamide structure were prepared and evaluated via an in vitro binding assay. Most of the novel ligands exhibited a nano-molar affinity for TSPO, which was better than that of DPA-714. Particularly, 11a exhibited a subnano-molar TSPO bindingaffinity with suitable lipophilicity for in vivo brain studies. After radiolabeling